These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 7848546)

  • 1. The beta 2-agonist controversy. Observations, explanations and relationship to asthma epidemiology.
    Sears MR; Taylor DR
    Drug Saf; 1994 Oct; 11(4):259-83. PubMed ID: 7848546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing patterns in asthma morbidity and mortality.
    Sears MR
    J Investig Allergol Clin Immunol; 1995; 5(2):66-72. PubMed ID: 7655702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International trends in sales of inhaled fenoterol, all inhaled beta-agonists, and asthma mortality, 1970-1992.
    Lanes SF; Birmann B; Raiford D; Walker AM
    J Clin Epidemiol; 1997 Mar; 50(3):321-8. PubMed ID: 9120532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse effects of beta-agonists: are they clinically relevant?
    Abramson MJ; Walters J; Walters EH
    Am J Respir Med; 2003; 2(4):287-97. PubMed ID: 14719995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The beta-agonist controversy.
    Taylor DR; Sears MR; Cockcroft DW
    Med Clin North Am; 1996 Jul; 80(4):719-48. PubMed ID: 8676612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asthma treatment: inhaled beta-agonists.
    Sears MR
    Can Respir J; 1998; 5 Suppl A():54A-9A. PubMed ID: 9753519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-agonists: what is the evidence that their use increases the risk of asthma morbidity and mortality?
    Beasley R; Pearce N; Crane J; Burgess C
    J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 2):S18-30. PubMed ID: 10452785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controversies involving inhaled beta-agonists and inhaled corticosteroids in the treatment of asthma.
    Fahy JV; Boushey HA
    Clin Chest Med; 1995 Dec; 16(4):715-33. PubMed ID: 8565410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concluding remarks: can we explain the association of beta-agonists with asthma mortality? A hypothesis.
    Hancox RJ
    Clin Rev Allergy Immunol; 2006; 31(2-3):279-88. PubMed ID: 17085800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of adrenergic beta agonists on morbidity and mortality of asthma].
    Bousquet J; Godard P; Michel FB
    Presse Med; 1993 Feb; 22(7):308-13. PubMed ID: 8099222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of beta-agonists and the risk of death and near death from asthma.
    Spitzer WO; Suissa S; Ernst P; Horwitz RI; Habbick B; Cockcroft D; Boivin JF; McNutt M; Buist AS; Rebuck AS
    N Engl J Med; 1992 Feb; 326(8):501-6. PubMed ID: 1346340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-acting beta-agonist research: a perspective. 1997.
    Sears MR
    Can Respir J; 2001; 8(5):349-55. PubMed ID: 11694915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Confounding by indication and channeling over time: the risks of beta 2-agonists.
    Blais L; Ernst P; Suissa S
    Am J Epidemiol; 1996 Dec; 144(12):1161-9. PubMed ID: 8956629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of severe life threatening asthma and beta agonist type: an example of confounding by severity.
    Garrett JE; Lanes SF; Kolbe J; Rea HH
    Thorax; 1996 Nov; 51(11):1093-9. PubMed ID: 8958891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. End of the New Zealand asthma mortality epidemic.
    Pearce N; Beasley R; Crane J; Burgess C; Jackson R
    Lancet; 1995 Jan; 345(8941):41-4. PubMed ID: 7799709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-acting beta-agonist treatment in patients with persistent asthma already receiving inhaled corticosteroids.
    Hancox RJ; Taylor DR
    BioDrugs; 2001; 15(1):11-24. PubMed ID: 11437672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of long-acting beta2-agonists in the treatment of asthma.
    Cazzola M; Matera MG
    Ther Adv Respir Dis; 2007 Oct; 1(1):35-46. PubMed ID: 19124346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Withdrawal of fenoterol and the end of the New Zealand asthma mortality epidemic.
    Beasley R; Pearce N; Crane J; Burgess C
    Int Arch Allergy Immunol; 1995; 107(1-3):325-7. PubMed ID: 7613161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: "Confounding by indication and channeling over time: the risks of beta2-agonists".
    Pearce N; Beasley R; Crane J; Burgess C
    Am J Epidemiol; 1997 Nov; 146(10):885-7. PubMed ID: 9384211
    [No Abstract]   [Full Text] [Related]  

  • 20. Optical illusions from visual data analysis: example of the New Zealand asthma mortality epidemic.
    Suissa S; Ernst P
    J Clin Epidemiol; 1997 Oct; 50(10):1079-88. PubMed ID: 9368515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.